Cephalalgia
- VIANA M, Hougaard A, Tronvik E, Winnberg IG, et al
Visual migraine aura iconography: A multicentre, cross-sectional study of
individuals with migraine with aura.
Cephalalgia. 2024;44:3331024241234809.
Headache
- ROSSIGNOL J, Ouimet T, Poras H, Dallel R, et al
Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan
in a preclinical model of migraine.
Headache. 2024 Feb 22. doi: 10.1111/head.14681.
- LANGDON RL, DiSabella MT, Strelzik JA
Screen time and pediatric headache: A scoping review of the literature.
Headache. 2024;64:211-225.
- HAN C, Lim JY, Koike N, Kim SY, et al
Regulation of headache response and transcriptomic network by the trigeminal
ganglion clock.
Headache. 2024;64:195-210.
- JICHA C, Pham K
Neuromodulation for primary headache disorders: Advantages and challenges.
Headache. 2024;64:226-228.
- PRADHAN SK, Gantenbein AR, Li Y, Shaban H, et al
Daith piercing: Revisited from the perspective of auricular acupuncture systems.
A narrative review.
Headache. 2024;64:131-140.
Lancet Neurol
- CHIANG CC, Porreca F, Robertson CE, Dodick DW, et al
Potential treatment targets for migraine: emerging options and future prospects.
Lancet Neurol. 2024;23:313-324.
- HAY DL
A future treatment horizon for migraine?
Lancet Neurol. 2024;23:226-227.
- TASSORELLI C, Nagy K, Pozo-Rosich P, Lanteri-Minet M, et al
Safety and efficacy of atogepant for the preventive treatment of episodic
migraine in adults for whom conventional oral preventive treatments have failed
(ELEVATE): a randomised, placebo-controlled, phase 3b trial.
Lancet Neurol. 2024 Feb 13:S1474-4422(24)00025.
- XU X, Dong L, Zhou J
ELEVATEd hope for patients after migraine treatment failure.
Lancet Neurol. 2024 Feb 13:S1474-4422(24)00072.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016